Stocktoria
ASP Isotopes Inc. ASPI
ASP Isotopes Inc. financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $23.8M | $4.1M | $433,026 | $0 |
| Gross profit | $3.4M | $1.6M | $138,970 | $0 |
| R&D expense | $12.4M | $3.1M | $764,581 | $1.3M |
| Operating income | -$59.9M | -$26.4M | -$16.0M | -$5.1M |
| Interest expense | — | — | $118,547 | $0 |
| Income tax | $282,000 | $111,000 | -$6,133 | $0 |
| Net income | -$159.8M | -$32.4M | -$16.3M | -$4.9M |
| EPS (diluted) | $-2.11 | $-0.63 | $-0.49 | — |
| Operating cash flow | -$37.8M | -$16.7M | -$5.4M | -$2.9M |
| Free cash flow | -$47.4M | -$26.4M | -$7.7M | -$7.4M |
| Cash & equivalents | $279.6M | $61.9M | $7.9M | — |
| Inventory | $1.1M | $66,000 | $0 | — |
| Total assets | $498.0M | $94.3M | $27.5M | $12.5M |
| Total liabilities | $235.1M | $43.2M | $8.7M | $2.7M |
| Shareholders' equity | $262.9M | $51.2M | $18.8M | $9.8M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +475.5% | +857.0% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.